Good evidence supports the use of terbinafine for treating T. tonsurans tinea capitis in children, and fair evidence supports its use in M. canis tinea capitis. Terbinafine has the advantage over griseofulvin of producing good results in a shorter time, making patient compliance less a problem. An important disadvantage is that it is available only in tablet form - there is no suspension. According to RCTs, the recommended regimen in children with tinea capitis is continuous therapy once daily for 4 weeks with dosage according to body weight: 62-5 mg/day for children weighing 10-20 kg; 125 mg/day for 20-40 kg; 250 mg/day for those weighing over 40 kg. M. canis infections may require treatment for 6-8 weeks. Terbinafine is not licensed for this indication in children in some countries.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.